Replimune Group, Inc.
Recent Filings
All 588 filings →| Form | Description | Date |
|---|---|---|
| 4 | OWNERSHIP DOCUMENT | Feb 20, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| 10-Q | 10-Q | Feb 3, 2026 |
| 8-K | FORM 8-K | Feb 3, 2026 |
| 8-K | FORM 8-K | Jan 12, 2026 |
| 4 | OWNERSHIP DOCUMENT | Dec 19, 2025 |
| 4 | OWNERSHIP DOCUMENT | Dec 19, 2025 |
| 4 | OWNERSHIP DOCUMENT | Dec 19, 2025 |
| 4 | OWNERSHIP DOCUMENT | Dec 19, 2025 |
| 4 | OWNERSHIP DOCUMENT | Dec 19, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Patel Sushil | Chief Executive Officer | Award / Grant | 200,000 | 533,576 | Dec 19, 2025 |
| Xynos Konstantinos | Chief Medical Officer | Award / Grant | 60,000 | 199,685 | Dec 19, 2025 |
| Hill Emily Luisa | Chief Financial Officer | Award / Grant | 60,000 | 194,368 | Dec 19, 2025 |
| Sarchi Christopher | Chief Commercial Officer | Award / Grant | 35,000 | 158,088 | Dec 19, 2025 |
| Schwendenman Andrew | Chief Accounting Officer | Award / Grant | 10,000 | 78,284 | Dec 19, 2025 |
| Patel Sushil | Chief Executive Officer | Sale | 10,000 @ $11.13 | 333,576 | Dec 2, 2025 |
| Sarchi Christopher | Chief Commercial Officer | Sale | 5,208 @ $9.10 | 123,088 | Nov 17, 2025 |
| Xynos Konstantinos | Chief Medical Officer | Sale | 7,248 @ $9.10 | 139,685 | Nov 17, 2025 |
| Hill Emily Luisa | Chief Financial Officer | Sale | 9,154 @ $5.37 | 134,368 | Aug 15, 2025 |
| Astley-Sparke Philip | — | Sale | 32,279 @ $8.06 | 1,405,071 | May 20, 2025 |